- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07488780
Språknettverksprehabilitasjon via fMRI Nevrofeedback
fMRI Nevrofeedback for Prehabilitering av Språknettverket hos Pasienter som Gjennomgår Radikal Gliomkirurgi
This is an interventional neuroimaging study that will examine whether fMRI neurofeedback can shift language network activity away from regions affected by glioma prior to surgery.
Studieoversikt
Detaljert beskrivelse
The primary objective of this study is to establish the feasibility and acceptability of implementing a brief, device-based fMRI neurofeedback (NF) intervention during the standard presurgical window in patients with WHO grade II-III gliomas involving eloquent language cortex.
The secondary objectives of this study are to obtain preliminary mechanistic and behavioral data regarding the effects of fMRI NF-based prehabilitation on language network organization and language performance. These secondary objectives are exploratory and intended to inform the design of a future randomized clinical trial.
The intervention will be conducted during the standard preoperative window and will not alter or delay clinical care. All participants will receive the same neurofeedback intervention as the primary goal of this study is to establish feasibility and generate pilot data. The study involves repeated within-subject assessments, including baseline and post-intervention neuropsychological testing and task-based fMRI measures, allowing each participant to serve as their own reference point for exploratory analyses.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Luca Pasquini, MD, PhD
- Telefonnummer: 203-688-2433
- E-post: luca.pasquini@yale.edu
Studiesteder
-
-
Connecticut
-
New Haven, Connecticut, Forente stater, 06520
- Rekruttering
- Yale School of Medicine
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Diagnosis of WHO grade II-III glioma involving eloquent language cortex
- Scheduled for surgical resection
- MRI-compatible
- Ability to perform the simple language tasks required for fMRI and neurofeedback
- Residence within 2 hours of Yale MRRC and ability and willingness to make multiple visits for study participation
Exclusion Criteria:
- Severe baseline aphasia precluding task performance
- Contraindications to MRI
- Significant cognitive/psychiatric comorbidity limiting compliance
- Concurrent enrollment in other interventional trials
- Claustrophobia of a degree that they cannot comfortably be scanned
- Inability or unwillingness to understand or follow the instructions
- Pregnancy or possible pregnancy
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Enhetens gjennomførbarhet
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: fMRI neurofeedback (NF) and Glioma
All participants will receive an fMRI NF intervention delivered as a presurgical prehabilitation strategy involving eloquent language cortex. The intervention will be conducted during the standard preoperative window and will not alter or delay clinical care. The study involves repeated within-subject assessments, including baseline and post-intervention neuropsychological testing and task-based fMRI measures. |
Real-time functional magnetic resonance imaging (fMRI) neurofeedback (NF) |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of participants enrolled to assess feasibility
Tidsramme: up to 6 months
|
Number of participants enrolled out of all screened |
up to 6 months
|
|
Number of participants completing all study visits to assess feasibility
Tidsramme: From initial neurosurgical evaluation to scheduled tumor resection, 7-10 days
|
Number of participants completing all study visits within the standard presurgical window |
From initial neurosurgical evaluation to scheduled tumor resection, 7-10 days
|
|
Number of device-related adverse events to assess safety
Tidsramme: From initial neurosurgical evaluation to scheduled tumor resection, 7-10 days
|
Number of device-related adverse events |
From initial neurosurgical evaluation to scheduled tumor resection, 7-10 days
|
|
Mean score Patient Experience Questionnaire (PEQ) to assess acceptability
Tidsramme: Post surgery at 10 days
|
Participant-reported acceptability and perceived burden as measured by the Patient Experience Questionnaire (PEQ). Total score range 1-5 with higher scores indicating better experiences. |
Post surgery at 10 days
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Michelle Hampson, PhD, Yale University
- Hovedetterforsker: Luca Pasquini, MD, PhD, Yale School of Medicin
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Neoplasmer
- Neoplasmer etter histologisk type
- Neoplasmer, kjertel og epitel
- Neoplasmer, Neuroepithelial
- Nevroektodermale svulster
- Neoplasmer, kjønnsceller og embryonale
- Neoplasmer, nervevev
- Glioma
- Diagnostiske teknikker og prosedyrer
- Diagnose
- Tomografi
- Diagnostisk avbildning
- Magnetisk resonansavbildning
Andre studie-ID-numre
- 2000041907
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .